4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
PDS Biotechnology Corporation (PDSB) operates in the Biotechnology industry and is headquartered in Princeton, United States with about 21 employees. Its market capitalization is roughly $41 million. In the fiscal year ended 2025-12-31, PDSB reported $0M in revenue and ($34M) in net income.
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($32M) | ($36M) | ($43M) | ($42M) |
| Net Income | ($34M) | ($38M) | ($43M) | ($41M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($6M) | ($7M) | ($8M) | ($8M) | ($9M) |
| Net Income | ($7M) | ($8M) | ($9M) | ($9M) | ($8M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $30M | $45M | $59M | $77M | — |
| Total Liabilities | $21M | $26M | $33M | $33M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PDSB viewer.
About TickerBase · Data methodology & sources